The Lions Eye Institute adheres to the highest levels of corporate governance and the Western Australian community, our patients and staff can be assured of our ongoing commitment to excellence.
Our governance framework ensures we operate strategically, with strong leadership and best practice decision-making.
In our clinical operations, we are committed to having clear responsibilities for managing safety and quality of care, as well as adherence to National Safety and Quality Health Services Standards and the Licensing Standards, Arrangements for Management, Staffing and Equipment in Day Hospitals – Class A.
The Medical Advisory Committee (MAC), comprising a small group of clinicians and executives, contributes to the governance and oversight of the operations of clinical services, and effective delivery of the clinical services strategy.
The Clinicians Forum is a representative committee comprising all Lions Eye Institute clinicians, and it considers and advises on matters relating to patient safety, quality of care, infection control and other risks, and refers issues for action to the MAC.
The Lions Eye Institute’s Quality and Safety Committee consists of representatives from areas of the Institute that relate to all quality and safety matters, including clinical services. The Committee oversees relevant policies, and promotes and monitors improvements in the quality and safety of Institute’s services.
The Credentialing Committee initiates and reviews the credentialing of high quality clinicians appointed to the Lions Eye Institute, and undertakes regular reviews.
Our research governance structure comprises four principal committees:
This committee has the broadest oversight of research capacity, governance and strategy. It provides confidence to the Lions Eye Institute Board that all research undertaken under the Institute’s banner is documented and compliant with the Lions Eye Institute’s research governance and standards. The committee is chaired by Board member, Professor Grant Waterer, and includes Board members and the Lions Eye Institute executive.
Scientific Advisory Panel (SAP)
This committee drives the research strategy and the processes to support implementation of the strategy. It engages with a range of external experts to develop and renew strategic directions and inform the Lions Eye Institute’s research strategy, as well as providing oversight and guidance to increase research governance capability and research outputs. The SAP is chaired by the Managing Director, Professor Bill Morgan, and includes members of the Lions Eye Institute’s Board as well as senior internal and external scientists.
Research Implementation Group (RIG)
The RIG aims to build research capability and allocate small internal grants to Lions Eye Institute researchers. It helps to enhance our strong research culture and build alliances for clinical trials. The RIG is chaired by senior Lions Eye Institute scientist, Dr Sam McLenachan, and includes senior research management and scientists.
Clinical Trials and Research Committee (CT&RC)
This committee builds research capability, culture and alliances for clinical trials. It supports the research governance framework, ensuring research is high quality, of scientific merit and ethical. It also ensures clinical trials are undertaken fairly and sustainably in line with the Lions Eye Institute’s strategic objectives, and facilitates the growth of translational research. The Committee is chaired by Lions Eye Institute clinician scientist, Dr Antony Clark, and includes the Manager Clinical Trials and key executives.
The five sub-committees of the Lions Eye Institutes Board provide oversight of key areas and includes:
- Finance, Audit and Investment Committee
- Research Committee
- Research Translation Committee
- Remuneration and Nominations Committee
- Risk and Compliance Committee